We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Mylan Settles Dispute Over Generic Orapred ODT

Law360, New York (October 10, 2012, 3:31 PM EDT) -- Mylan Inc. has entered into a licensing agreement that will allow it to sell its generic version of anti-inflammatory Orapred ODT, ending a patent infringement dispute with rivals Shionogi Pharma Inc....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.